GENEVA, June 2 -- NOVARTIS AG (Lichtstrasse 354056 Basel) filed a patent application (PCT/IB2024/061580) for "SUBSTITUTED IMIDAZOARENES AND METHODS OF THEIR USE" on Nov 19, 2024. With publication no. WO/2025/109474, the details related to the patent application was published on May 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): COLE, Justin (Novartis Institutes for BioMedical Research, Inc.250 Massachusetts AvenueCambridge, Massachusetts 02139), JOHNSON, Alyssa Miranda (Novartis Institutes for BioMedical Research, Inc.250 Massachusetts AvenueCambridge, Massachusetts 02139), KARKI, Rajes...